We came across a bullish thesis on BioMarin Pharmaceutical Inc. on Value investing subreddit by ProudlyRegarded. In this article, we will summarize the bulls’ thesis on BMRN. BioMarin Pharmaceutical Inc.’s share was trading at $57.77 as of September 5th. BMRN’s trailing and forward P/E were 17.04 and 10.80 respectively according to Yahoo Finance.
Copyright: dolgachov / 123RF Stock Photo
BioMarin Pharmaceutical Inc. is a global biotechnology company focused on translating genetic...
